1 |
100-52-7 |
AKR1B8 |
Rattus norvegicus |
[AKR1B8 protein co-treated with NADP] affects the reduction of benzaldehyde |
affects^cotreatment|affects^reduction |
18845131 |
2 |
100-52-7 |
AKR1B8 |
Rattus norvegicus |
[AKR1B8 protein co-treated with NADP] affects the reduction of benzaldehyde |
affects^cotreatment|affects^reduction |
18845131 |
3 |
100-52-7 |
ALDH2 |
Homo sapiens |
benzaldehyde inhibits the reaction [4-dimethylaminocinnamaldehyde binds to ALDH2 protein] |
affects^binding|decreases^reaction |
10609638 |
4 |
100-52-7 |
ALDH2 |
Homo sapiens |
benzaldehyde inhibits the reaction [4-dimethylaminocinnamaldehyde binds to ALDH2 protein] |
affects^binding|decreases^reaction |
10609638 |
5 |
100-52-7 |
ALDH3A1 |
Homo sapiens |
[ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde |
affects^cotreatment|increases^oxidation |
10856427 |
6 |
100-52-7 |
ALDH3A1 |
Homo sapiens |
[ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde |
affects^cotreatment|increases^oxidation |
10856427 |
7 |
100-52-7 |
ALDH3A1 |
Homo sapiens |
[ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde |
affects^cotreatment|increases^oxidation |
10856427 |
8 |
100-52-7 |
ALDH3A1 |
Homo sapiens |
[ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde |
affects^cotreatment|increases^oxidation |
10856427 |
9 |
100-52-7 |
ALDH3B1 |
Homo sapiens |
benzaldehyde binds to ALDH3B1 protein |
affects^binding |
20699116 |
10 |
100-52-7 |
ALDH3B1 |
Homo sapiens |
benzaldehyde binds to ALDH3B1 protein |
affects^binding |
20699116 |
11 |
100-52-7 |
AR |
Rattus norvegicus |
benzaldehyde inhibits the reaction [Metribolone binds to AR protein] |
affects^binding|decreases^reaction |
3695475 |
12 |
100-52-7 |
AR |
Rattus norvegicus |
benzaldehyde inhibits the reaction [Metribolone binds to AR protein] |
affects^binding|decreases^reaction |
3695475 |
13 |
100-52-7 |
MT2 |
Oryctolagus cuniculus |
benzaldehyde inhibits the reaction [Zinc binds to MT2 protein] |
affects^binding|decreases^reaction |
16930132 |
14 |
100-52-7 |
MT2 |
Oryctolagus cuniculus |
benzaldehyde inhibits the reaction [Zinc binds to MT2 protein] |
affects^binding|decreases^reaction |
16930132 |
15 |
100-52-7 |
MYS |
Drosophila melanogaster |
MYS results in increased susceptibility to benzaldehyde |
increases^response to substance |
16763085 |
16 |
100-52-7 |
MYS |
Drosophila melanogaster |
MYS results in increased susceptibility to benzaldehyde |
increases^response to substance |
16763085 |
17 |
100-52-7 |
OBP2 |
Chilo suppressalis |
benzaldehyde binds to OBP2 protein |
affects^binding |
19523072 |
18 |
100-52-7 |
OBP2 |
Chilo suppressalis |
benzaldehyde binds to OBP2 protein |
affects^binding |
19523072 |
19 |
100-52-7 |
OLFR151 |
Mus musculus |
benzaldehyde binds to and results in increased activity of OLFR151 protein |
affects^binding|increases^activity |
11943806 |
20 |
100-52-7 |
OLFR151 |
Mus musculus |
benzaldehyde binds to and results in increased activity of OLFR151 protein |
affects^binding|increases^activity |
11943806 |
21 |
100-52-7 |
OR43A |
Drosophila melanogaster |
benzaldehyde binds to OR43A protein |
affects^binding |
11481495 |
22 |
100-52-7 |
OR43A |
Drosophila melanogaster |
benzaldehyde binds to OR43A protein |
affects^binding |
11481495 |
23 |
100-52-7 |
SLC2A1 |
Mus musculus |
[benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein |
affects^cotreatment|decreases^activity |
20955755 |
24 |
100-52-7 |
SLC2A1 |
Mus musculus |
[benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein |
affects^cotreatment|decreases^activity |
20955755 |
25 |
100-52-7 |
SLC2A1 |
Mus musculus |
benzaldehyde results in increased activity of SLC2A1 protein |
increases^activity |
20955755 |
26 |
100-52-7 |
SLC2A1 |
Mus musculus |
benzaldehyde results in increased activity of SLC2A1 protein |
increases^activity |
20955755 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|
1 | | |
|
100-52-7 |
Benzoic aldehyde |